908 Devices Retained Earnings (Accumulated Deficit) 2020-2024 | MASS
908 Devices retained earnings (accumulated deficit) from 2020 to 2024. Retained earnings (accumulated deficit) can be defined as profits reinvested in the corporation after dividends have been paid out.
| 908 Devices Annual Retained Earnings (Accumulated Deficit) (Millions of US $) |
|
|---|---|
| 2024 | $-243 |
| 2023 | $-171 |
| 2022 | $-134 |
| 2021 | $-101 |
| 2020 | $-78 |
| 2019 | $-66 |
| 908 Devices Quarterly Retained Earnings (Accumulated Deficit) (Millions of US $) |
|
|---|---|
| 2024-12-31 | $-243 |
| 2024-09-30 | $-223 |
| 2024-06-30 | $-194 |
| 2024-03-31 | $-182 |
| 2023-12-31 | $-171 |
| 2023-09-30 | $-163 |
| 2023-06-30 | $-156 |
| 2023-03-31 | $-147 |
| 2022-12-31 | $-134 |
| 2022-09-30 | $-124 |
| 2022-06-30 | $-118 |
| 2022-03-31 | $-110 |
| 2021-12-31 | $-101 |
| 2021-09-30 | $-97 |
| 2021-06-30 | $-92 |
| 2021-03-31 | $-85 |
| 2020-12-31 | $-78 |
| 2020-09-30 | |
| 2020-06-30 | |
| 2020-03-31 | |
| 2019-12-31 | $-66 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | MED INSTRUMENTS | $0.200B | $0.060B |
| 908 Devices Inc. is a purpose-built handheld and desktop mass spec devices for chemical and biomolecular analysis. It conducts research, designs and manufactures products of mass spectrometry, microfluidic separations, software automation and machine learning. 908 Devices Inc. is headquartered in Boston. | |||